ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. (2022)
Attributed to:
Mitochondria and cell death regulation following toxic injury
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41388-022-02251-8
PubMed Identifier: 35301407
Publication URI: http://europepmc.org/abstract/MED/35301407
Type: Journal Article/Review
Volume: 41
Parent Publication: Oncogene
Issue: 18
ISSN: 0950-9232